Business Round-Up: Q3–Q4 2025 Activity in the Nephrology Industry
Abstract
Twice a year, Kidney News publishes a high-level review of US Food and Drug Administration (FDA) regulatory approvals, scientific results from industry, investments, and mergers and acquisitions to ensure the ASN membership is well-informed. More than 500 data points, collected from July 1 to December 31, 2025, generated the following analysis and summaries.
Fields of Study & Subjects
Pharmaceutical Economics and Policy
Dialysis and Renal Disease Management
Pharmaceutical industry and healthcare
Publication details
- Journal / source
- Kidney News
- Volume
- 18
- Issue
- 2
- Pages
- 10–11
- Publication date
- 6 February 2026